Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EasySix
- Development stage
- Unknown
- Lead developer
- Panacea Biotec
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
EasySix is a fully liquid hexavalent vaccine developed by Panacea Biotec, designed to protect infants against six major childhood diseases: Diphtheria, Tetanus, Pertussis (whole-cell), Hepatitis B, Haemophilus influenzae type b (Hib), and Polio (Inactivated Polio Vaccine - IPV). As a fully liquid formulation, it eliminates the need for reconstitution, thereby reducing the risk of contamination and administration errors while simplifying the vaccination process for healthcare providers. The vaccine is the result of a significant collaboration between Panacea Biotec and the Serum Institute of India (SII), aimed at addressing global shortages of IPV-containing vaccines and meeting the high demand in international markets. It is typically administered as a primary series in infants to ensure broad-spectrum protection during early development.
- Brand names
- EasySix
- Other names
- DTwP-HepB-Hib-IPV vaccineHexavalent vaccine
02
Targets
HBsAg (Hepatitis B surface antigen)Diphtheria toxin
Beyond the preview
Go deeper on EasySix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EasySix.